Biodexa Pharmaceuticals Plc - Ordinary Shares, nominal value 0.00005 GBP per share (BDRX)
Historical Holders from Q4 2024 to Q3 2025
-
Type / Class
-
Equity / Ordinary Shares, nominal value 0.00005 GBP per share
-
Symbol
-
BDRX on Nasdaq
-
Shares outstanding
-
25,770,441,176
-
Price per share
-
$0.86
-
All holders as of 30 Sep 2025
-
Q3 2025
-
Total 13F shares
-
0
-
Total reported value
-
$0
-
Share change
-
-19,666
-
Value change
-
-$17,010
-
Number of holders
-
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Significant Owners of Biodexa Pharmaceuticals Plc - Ordinary Shares, nominal value 0.00005 GBP per share (BDRX) based on Schedule 13D/G filings
| Filer |
Ownership |
Change % |
Holdings Value |
Net Change |
Nb Shares |
Change % |
Reporting Name |
Report Period |
|
C/M CAPITAL PARTNERS, LP
|
6.8%
|
|
$2,611,061,100
|
+$2,611,061,100
|
1,752,390,000
|
|
Jonathan Juchno
|
20 May 2025
|
As of 30 Sep 2025,
Biodexa Pharmaceuticals Plc - Ordinary Shares, nominal value 0.00005 GBP per share (BDRX) has
0
institutional shareholders
filing 13F forms.
They reported no common stock holdings, but disclosed options positions.
Institutional Holders of Biodexa Pharmaceuticals Plc - Ordinary Shares, nominal value 0.00005 GBP per share (BDRX) across Reporting Periods
| Period |
Reported Shares, Excl. Options
|
Value, Excl. Options
|
Value Change
|
Puts Notional Value
|
Calls Notional Value
|
Price
|
Investors
|
|
2025 Q3
|
0
|
$0
|
-$17,010
|
|
|
$0.86
|
0
|
|
2025 Q2
|
19,666
|
$17,010
|
-$1,756
|
|
|
$0.86
|
4
|
|
2025 Q1
|
21,314
|
$28,132
|
+$18,574
|
|
|
$1.32
|
6
|
|
2024 Q4
|
7,242
|
$29,334
|
+$29,330
|
|
|
$4.05
|
4
|